Hubei Biocause Pharmaceutical Co., Ltd. (SHE:000627)

SHE:000627 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020	Dec 31, 2019
Investments in Debt Securities	100	38,435	35,490	36,547	34,091	27,806
Investments in Equity & Preferred Securities	9,857	97,160	95,756	79,715	85,134	92,733
Policy Loans	1,258	1,114	946.6	902.64	838.81	628.67
Other Investments	122,812	1,109	5,563	4,499	1,656	3,370
Total Investments	156,366	159,101	151,039	135,297	135,638	135,887
Cash & Equivalents	8,332	28,154	26,309	23,250	26,857	12,992
Reinsurance Recoverable	3,266	257.84	249.72	2,037	3,466	1,940
Other Receivables	98,429	93,938	84,480	77,518	49,054	38,874
Separate Account Assets	4,318	4,656	5,154	5,992	4,434	2,817
Property, Plant & Equipment	1,459	1,291	844.07	830.33	580.44	567.17
Goodwill	6,193	6,193	6,192	6,192	6,192	6,186
Other Intangible Assets	259.99	283.2	299.34	269.71	190	109.42
Other Current Assets	3,871	4,149	10,523	10,224	10,716	3,672
Long-Term Deferred Tax Assets	1,309	2,654	2,280	1,010	976.19	944.16
Long-Term Deferred Charges	-	19.4	25.92	31.38	-	25.15
Other Long-Term Assets	1,351	1,241	1,201	1,251	1,298	1,259
Total Assets	285,154	301,936	288,599	263,904	239,403	205,274
Accounts Payable	670.96	949.05	206.9	93.51	35.01	156.51
Accrued Expenses	188.36	591.64	1,132	1,239	906.58	786.62
Insurance & Annuity Liabilities	220,773	231,001	215,704	199,703	187,869	158,624
Unpaid Claims	3,208	2,808	1,133	1,089	858.86	675.49
Unearned Premiums	9.04	13.93	182.58	238.08	95.3	29.69
Reinsurance Payable	209.18	217.59	225.77	206.87	1,080	85.8
Short-Term Debt	11,976	18,248	21,190	9,426	4,584	6,180
Current Income Taxes Payable	45.57	9.9	11.91	23.83	7.76	202.84
Long-Term Debt	5,510	7,099	6,791	6,132	2,868	-
Long-Term Leases	68.99	71.56	89.58	111.18	-	-
Long-Term Deferred Tax Liabilities	1,397	1,378	1,348	1,281	1,519	1,049
Separate Account Liability	4,318	4,656	5,154	5,992	4,434	2,817
Other Current Liabilities	744.75	1,217	761.4	844	555.17	295.27
Other Long-Term Liabilities	27.03	37.36	56.48	42.09	1.43	17.38
Total Liabilities	249,149	268,302	253,996	226,429	204,815	170,920
Common Stock	4,941	4,941	4,941	4,941	4,941	4,941
Additional Paid-In Capital	11,008	11,041	11,094	11,094	11,095	11,095
Retained Earnings	5,254	5,588	6,783	6,533	6,112	6,026
Comprehensive Income & Other	596.34	-978.79	-1,405	-15.1	-1,013	-838.78
Total Common Equity	21,800	20,590	21,412	22,553	21,135	21,223
Minority Interest	14,205	13,044	13,191	14,921	13,453	13,130
Shareholders' Equity	36,005	33,634	34,603	37,475	34,588	34,353
Total Liabilities & Equity	285,154	301,936	288,599	263,904	239,403	205,274
Filing Date Shares Outstanding	4,941	4,941	4,941	4,941	4,941	4,941
Total Common Shares Outstanding	4,941	4,941	4,941	4,941	4,941	4,941
Total Debt	17,555	25,419	28,070	15,669	7,452	6,180
Net Cash (Debt)	-9,224	2,735	-1,760	7,582	19,405	6,812
Net Cash Growth	-	-	-	-60.93%	184.87%	-49.77%
Net Cash Per Share	-1.84	0.55	-0.39	1.61	4.01	1.38
Book Value Per Share	4.41	4.17	4.33	4.56	4.28	4.30
Tangible Book Value	15,347	14,114	14,920	16,091	14,753	14,927
Tangible Book Value Per Share	3.11	2.86	3.02	3.26	2.99	3.02
Buildings	-	1,292	702.83	633.87	481.32	463.3
Machinery	-	90.97	86.15	79.67	64.34	54.75
Construction In Progress	-	3.38	95.45	95.9	102.34	99.65

Source: S&P Capital IQ. Insurance template. Financial Sources.